ZOLACABTAGENE AUTOLEUCEL
UNII DU963TX85S

Substance Identification & Data

This profile provides standardized clinical and technical data for Zolacabtagene Autoleucel, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DU963TX85S.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
DU963TX85S
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ZOLACABTAGENE AUTOLEUCEL
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C175049
National Cancer Institute reference terminology for clinical and research data.
INN ID
13483
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
MN-86
Identifier assigned by the United States Adopted Names Council.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
ITIS TSN
180092
Taxonomic Serial Number for species identified in the Integrated Taxonomic Information System.
NCBI Taxonomy
9606
Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zolacabtagene Autoleucel. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZOLACABTAGENE AUTOLEUCEL

Common Names & Synonyms

BMS-986353 IS AN INVESTIGATIONAL CD19-TARGETED CAR T-CELL PRODUCT. THE CD19-SPECIFIC CAR CONSISTS OF A SINGLE-CHAIN VARIABLE FRAGMENT (SCFV) BINDING DOMAIN DERIVED FROM A CD19-SPECIFIC MONOCLONAL ANTIBODY (MAB; FMC63), AN IGG-DERIVED HINGE REGION, A CD28 TRANSMEMBRANE DOMAIN, AND THE CD137 (41BB) AND CD3.ZETA. CHAIN SIGNALING DOMAINS. THE THIRD-GENERATION SIN LENTIVIRAL VECTOR, WHICH ENCODES THE CAR DOMAINS DESCRIBED ABOVE, ALSO ENCODES A TRUNCATED HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR (EGFRT) THAT IS EXPRESSED SEPARATELY FROM THE CD19 CAR ON THE T CELL SURFACE
CC 97540 [WHO-DD]
ZOLACABTAGENE AUTOLEUCEL [USAN]

Technical Codes

BMS-986353
CC-97540

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus